Keywords
polimorfismo genético
flebotomia
ferritina sérica
How to Cite
Abstract
Background: Hemochromatosis is an autosomal recessive disorder caused by excessive iron overload in parenchymal organs. In Brazil, the prevalence of hereditary hemochromatosis (HH) may vary compared to other countries due to different ethnical backgrounds according to the geographic region studied. The prevalence of C282Y mutation of the HFE gene ranges from three to eight times lower in Brazilians than in Caucasians of Northern European origin. Methods: A retrospective cross-sectional study was carried out in 222 patients submitted to therapeutic phlebotomy between March 2011 and July 2014 in a tertiary hospital blood center. The prevalence of HH was determined in 89 (47.3%) out of 188 (84.6%) patients presenting hyperferritinemia, and divided in two genotype groups: C282Y mutation and other mutations. The HH patients’ geographical and clinical characteristics, serum ferritin rate (SF) and transferrin saturation (TS) were analyzed. Results: The HH group consisted of 71 males (79.7%) and 18 (20.3%) females, with a median age of 51.5 ± 10.6 years. There were 36 (40.0%) symptomatic patients and 65 (73.0%) tested positive for the HFE mutation. The initial baseline TS values were significantly higher in primary HH patients (48.6%, IC 95% 43.2% - 55.7%) compared to those with secondary HH (35.0%, IC 95% 27.5% 41.8%, p=0.001). Conclusion: The prevalence of C282Y mutation was higher in this population from the South region compared to previous reports in the Brazilian population, yet inferior to that of Northern Europeans.
References
Powell LW. Diagnosis of hemochromatosis. Semin Gastrointest Dis. 2002; 13(2):80-8.
Enns CA. Possible roles of the hereditary hemochromatosis protein, HFE, in regulating cellular iron homeostasis.Biol Res. 2006; 39(1):105-11.
Martinelli ALC. Hemocromatose hereditária: muito além do HFE. Sociedade Brasileira de Hepatologia, 2011, 3-6.
Franchini M. Recent acquisitions in the management of iron overload. Ann Hematol. 2005;84(10):640-5.
Pietrangelo A. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology. 2010;139(2):393-408.
Cançado RD, Chiattone, CS. Visão atual da hemocromatose hereditária. Revista Brasileira de Hematologia e Hemoterapia. 2010; 32(6):469-475.
Yen AW et al. Revisiting Hereditary Hemochromatosis:Current Concepts and Progress. The American Journal of Medicine. 2006; 119, 391-399.
Porto G et al. EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH). European Journal of Human Genetics. 2016; 24, 479-495.
Panch SR, Yau YY, West K, Diggs K, Sweigart T, Leitman SF. Initial serum ferritin predicts number of therapeutic phlebotomies to iron depletion in secondary iron overload. Transfusion. 2014 Sep 11. doi: 10.1111/trf.12854.
Angulo IL et al. Sangria Terapêutica. Medicina, Ribeirão Preto, Medicina. 1999 ;32: 290-293.
Leão GDR. Análise das mutações C282Y e H65D no gene da proteína HFE em pacientes com hiperferritinemia. Revista Brasileira de Hematologia e Hemoterapia. 2008; 30(3): 257-258.
Cherfane CE, Hollenbeck RD, Go J, Brown KE. Hereditary hemochromatosis: missed diagnosis or misdiagnosis. Am J Med. 2013; 126(11):1010-5.
Olynyk JK, Trinder D, Ramm GA, Britton RS, Bacon BR. Hereditary hemochromatosis in the post-HFE era. Hepatology. 2008; 48(3):991-1001.
Costa M et al. Effects of Highly Conserved Major Histocompatibility Complex (MHC) Extended Haplotypes on Iron and Low CD8+T Lymphocyte Phenotypes in HFE C282Y Homozygous Hemochromatosis Patients from Three Geographically Distant Areas. PLoS One. 2013 25; 8 (11):1-12.
Wojcik JP, Speechley MR, Kertesz AE, Chakrabarti S, Adams PC. Natural Natural history of C282Y homozygotes for hemochromatosis.history of C282Y homozygotes for hemochromatosis. Can J Gastroenterol. 2002; 16(5):297-302.
Ferreira, ACS et al. Prevalence of C282Y and H63D mutations in the HFE gene of Brasilian individuals with clinical suspicion of hereditary hemochromatosis. Revista Brasileira de Hematologia e Hemoterapia. , 2008; 30:5, 379 -383.
Crownover BK, Covey CJ. Hereditary hemochromatosis. Am Fam Physician. 2013 1;87(3):183-90.
Tavill AS ; American Association for the Study of Liver Diseases; American College of Gastroenterology; American Gastroenterological Association. Diagnosis and management of hemochromatosis. Hepatology. 2001; 33(5):1321-8.
Martinelli ALC. et al. Hereditary hemochromatosis in a Brazilian university in São Paulo State (1990-2000). Genectis and Molecular Reserch. 2005; 4(1): 31-38.
Fahim F et al .Iron Overload. Haematology Updates. 2011, 11-16.
Cançado RD et al. Estudo das mutações C282Y, H63D e S65C do gene HFE em doentes brasileiros com sobrecarga de ferro. Revista Brasileira de Hematologia e Hemoterapia. 2007; 29 (4):351-360.]
Leal FP et al .Ferritina em doadores de sangue de Maringuá, Paraná, Brasil. Brazilian Journal of Surgery and Clinical Research – BJSCR.2014; 7(1).5-12.
Mast AE, Lee TH, Schlumpf KS, Wright DJ, Johnson B, Carrick DM, Cable RG, Kiss JE, Glynn SA, Steele WR, Murphy EL, Sacher R,Busch MP; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II). The impact of HFE mutations on haemoglobin and iron status in individuals experiencing repeated iron loss through blood donation*.Br J Haematol. 2012;156 (3):388-401.
Bonini-Domingos CR Aumento de ferro, hemocromatose hereditária e defeitos no gene HFE. O que conhecemos na população brasielira. Revista Brasileira de Hematologia e Hemoterapia. 2007; 29(4): 339 -43.
Santos PCJL. Alterações moleculares associadas à hemocromatose hereditária. Revista Brasileira de Hematologia e Hemoterapia. 2009; 31(3):192-202.
Brissot P, de Bels F. Current approaches to the management of hemochromatosis. Hematology Am Soc Hematol Educ Program. 2006:36-41.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Cristiane da Silva Rodrigues de Araujo, Eduardo Augusto Maciel Pitt, Eliane Bianchini, Bruna Accorsi Machado, Jaqueline Soldá Palaoro, Lisia Hoppe, Adriano Pasqualotti, Luiz Bettinelli